middle.news
EZZ Life Science Posts Modest Revenue Rise Amid Profit Dip
4:16pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
EZZ Life Science Posts Modest Revenue Rise Amid Profit Dip
4:16pm on Friday 29th of August, 2025 AEST
Key Points
Revenue up 0.65% to $66.87 million
Profit after tax down 3.36% to $6.73 million
Net tangible assets per share increased to 59.49 cents
Dividends maintained at 2.00 cents per share, fully franked
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ezz Life Science (ASX:EZZ)
OPEN ARTICLE